Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.085 USD | +4.25% | +56.62% | -20.22% |
May. 02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
Apr. 30 | Top Midday Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.22% | 2.64M | |
+8.49% | 105B | |
-1.18% | 104B | |
+5.79% | 22.94B | |
-12.66% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.43% | 16.96B | |
+8.05% | 14.16B | |
+38.95% | 12.63B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Oppenheimer Adjusts Cyclacel Pharmaceuticals Price Target to $8 From $10, Maintains Outperform Rating